##common.pageHeaderLogo.altText##

Original article

Vol. 155 No. 7 (2025)

Comparing coverage of medically indicated reduction mammoplasty among Swiss health insurers: a retrospective study

Cite this as:
Swiss Med Wkly. 2025;155:3674
Published
07.07.2025

Summary

BACKGROUND: Reduction mammoplasty is commonly used to treat macromastia, highlighting the need to address the physical and psychosocial issues associated with breast hypertrophy. However, clear inconsistencies in insurance coverage and varying criteria for medically necessary surgery are evident. The compliance of Swiss insurance companies with the 2019 recommendations of the Swiss Society of Medical Officers and Insurance Physicians has not been fully assessed.

AIM: This study aimed to investigate the proportion and variability in cost approvals for reduction mammoplasty among Swiss insurers, focusing on differences in their approval and denial rates.

METHODS: A retrospective study was conducted on patients presenting with breast disease at Spital Thurgau AG between January 2016 and December 2022. It analysed the proportion and variability in cost approval rates for reduction mammoplasty among different insurance providers. Demographic patient data were collected and statistically analysed using chi-squared and Fisher’s exact tests to evaluate if a statistically significant relationship exists between insurance providers and cost approval. Only Swiss insurance providers servicing at least five patients in the final cohort were included.

RESULTS: Between January 2016 and December 2022, 1105 patients with breast disease were evaluated at Spital Thurgau AG, of whom 210 were eligible for this study on reduction mammoplasty cost approvals. Of the 210 cost approval requests made to nine different insurance companies, 54% were approved. Approval rates differed significantly among insurers (p = 0.003).

CONCLUSION: This study uncovered an elevated rate of cost approval denials, which depended significantly on the insurance provider. To ensure that the costs of a medically indicated breast reduction are covered consistently and fairly, a review of existing guidelines and their implementation is necessary to improve the system.

References

  1. ISAPS. ISAPS International survey on aesthetic/cosmetic procedure. 2018. Available from: https://www.isaps.org/media/wifiy3oo/isaps-global-survey-results-2018-1.pdf
  2. Benditte-Klepetko H, Leisser V, Paternostro-Sluga T, Rakos M, Trattnig S, Helbich T, et al. Hypertrophy of the breast: a problem of beauty or health? J Womens Health (Larchmt). 2007 Sep;16(7):1062–9. doi: https://doi.org/10.1089/jwh.2006.0183
  3. Kalliainen LK; ASPS Health Policy Committee. ASPS clinical practice guideline summary on reduction mammaplasty. Plast Reconstr Surg. 2012 Oct;130(4):785–9. doi: https://doi.org/10.1097/PRS.0b013e318262f0c0
  4. Morris MP, Butler PD. Insurance Coverage of Reduction Mammaplasty: A Need for New Criteria. Plast Reconstr Surg. 2021 Sep;148(3):520e–1e. doi: https://doi.org/10.1097/PRS.0000000000008272
  5. Collins ED, Kerrigan CL, Kim M, Lowery JC, Striplin DT, Cunningham B, et al. The effectiveness of surgical and nonsurgical interventions in relieving the symptoms of macromastia. Plast Reconstr Surg. 2002 Apr;109(5):1556–66. doi: https://doi.org/10.1097/00006534-200204150-00011
  6. Lonie S, Sachs R, Shen A, Hunter-Smith DJ, Rozen WM, Seifman M. A systematic review of patient reported outcome measures for women with macromastia who have undergone breast reduction surgery. Gland Surg. 2019 Aug;8(4):431–40. doi: https://doi.org/10.21037/gs.2019.03.08
  7. Mello AA, Domingos NA, Miyazaki MC. Improvement in quality of life and self-esteem after breast reduction surgery. Aesthetic Plast Surg. 2010 Feb;34(1):59–64. doi: https://doi.org/10.1007/s00266-009-9409-x
  8. Singh KA, Losken A. Additional benefits of reduction mammaplasty: a systematic review of the literature. Plast Reconstr Surg. 2012 Mar;129(3):562–70. doi: https://doi.org/10.1097/PRS.0b013e31824129ee
  9. Perdikis G, Dillingham C, Boukovalas S, Ogunleye AA, Casambre F, Dal Cin A, et al. American Society of Plastic Surgeons Evidence-Based Clinical Practice Guideline Revision: reduction Mammaplasty. Plast Reconstr Surg. 2022 Mar;149(3):392e–409e. doi: https://doi.org/10.1097/PRS.0000000000008860
  10. Bai J, Rosen CM, Ngaage LM, McNichols CH, Diaconu SC, Ihenatu C, et al. Longevity of Outcomes Following Reduction Mammoplasty. Eplasty. 2019 Jul;19:e18.
  11. Rogliani M, Gentile P, Labardi L, Donfrancesco A, Cervelli V. Improvement of physical and psychological symptoms after breast reduction. J Plast Reconstr Aesthet Surg. 2009 Dec;62(12):1647–9. doi: https://doi.org/10.1016/j.bjps.2008.06.067
  12. Wampler AT, Powelson IA, Homa K, Freed GL. BREAST-Q Outcomes before and after Bilateral Reduction Mammaplasty. Plast Reconstr Surg. 2021 Mar;147(3):382e–90e. doi: https://doi.org/10.1097/PRS.0000000000007605
  13. Becker H. Breast reduction insurance denials. Plast Reconstr Surg. 2004 Nov;114(6):1687.
  14. Kerrigan CL, Collins ED, Kim HM, Schnur PL, Wilkins E, Cunningham B, et al. Reduction mammaplasty: defining medical necessity. Med Decis Making. 2002;22(3):208–17. doi: https://doi.org/10.1177/0272989X0202200309
  15. Admin B. Swiss Federal Health Insurance Act (KVG/LAMal). 1996. Available from: https://www.bag.admin.ch/bag/en/home/versicherungen/krankenversicherung.html
  16. Ngaage LM, Knighton BJ, McGlone KL, Benzel CA, Rada EM, Bluebond-Langner R, et al. Health Insurance Coverage of Gender-Affirming Top Surgery in the United States. Plast Reconstr Surg. 2019 Oct;144(4):824–33. doi: https://doi.org/10.1097/PRS.0000000000006012
  17. Ngaage LM, Rose J, Pace L, Kambouris AR, Rada EM, Kligman MD, et al. A Review of National Insurance Coverage of Post-bariatric Upper Body Lift. Aesthetic Plast Surg. 2019 Oct;43(5):1250–6. doi: https://doi.org/10.1007/s00266-019-01420-7
  18. Rasko YM, Rosen C, Ngaage LM, AlFadil S, Elegbede A, Ihenatu C, et al. Surgical Management of Gynecomastia: A Review of the Current Insurance Coverage Criteria. Plast Reconstr Surg. 2019 May;143(5):1361–8. doi: https://doi.org/10.1097/PRS.0000000000005526
  19. Rosen CM, Ngaage LM, Rada EM, Slezak S, Kavic S, Rasko Y. Surgical Management of Diastasis Recti: A Systematic Review of Insurance Coverage in the United States. Ann Plast Surg. 2019 Oct;83(4):475–80. doi: https://doi.org/10.1097/SAP.0000000000001694
  20. Boukovalas S, Boson AL, Padilla PL, Sljivich M, Tran JP, Spratt H, et al. Insurance Denials in Reduction Mammaplasty: How Can We Serve Our Patients Better? Plast Reconstr Surg. 2020 Aug;146(2):127e–36e. doi: https://doi.org/10.1097/PRS.0000000000006968
  21. Nguyen JT, Wheatley MJ, Schnur PL, Nguyen TA, Winn SR. Reduction mammaplasty: a review of managed care medical policy coverage criteria. Plast Reconstr Surg. 2008 Apr;121(4):1092–100. doi: https://doi.org/10.1097/01.prs.0000304238.43482.9c
  22. Rawes CM, Ngaage LM, Borrelli MR, Puthumana J, Slezak S, Rasko YM. Navigating the Insurance Landscape for Coverage of Reduction Mammaplasty. Plast Reconstr Surg. 2020 Nov;146(5):539e–47e. doi: https://doi.org/10.1097/PRS.0000000000007241
  23. Wagner DS, Alfonso DR. The influence of obesity and volume of resection on success in reduction mammaplasty: an outcomes study. Plast Reconstr Surg. 2005 Apr;115(4):1034–8. doi: https://doi.org/10.1097/01.PRS.0000154213.06888.F9
  24. Frey JD, Koltz PF, Bell DE, Langstein HN. The complex insurance reimbursement landscape in reduction mammaplasty: how does the American plastic surgeon navigate it? Ann Plast Surg. 2014 Jan;72(1):23–9. doi: https://doi.org/10.1097/01.SAP.0000435778.81934.cd
  25. Koltz PF, Frey JD, Langstein HN. Insurance coverage and reduction mammaplasty: a systematic review of current health care policies. Plast Reconstr Surg. 2013 Oct;132(4):692e–3e. doi: https://doi.org/10.1097/PRS.0b013e3182a014f6
  26. Spector JA, Karp NS. Reduction mammaplasty: a significant improvement at any size. Plast Reconstr Surg. 2007 Sep;120(4):845–50. doi: https://doi.org/10.1097/01.prs.0000277660.49802.76
  27. Burger A, Lindenblatt N, Studer S. Mammareduktionsplastik. Schweizerische Ärzte der Vertrauens- und Versicherungsärzte. 2019. Available from: http://www.vertrauensaerzte.ch/manual/4/mammareduktionspl/
  28. Regnault P. Breast ptosis. Definition and treatment. Clin Plast Surg. 1976 Apr;3(2):193–203. doi: https://doi.org/10.1016/S0094-1298(20)30220-0
  29. Spear SL, Baker JL Jr. Classification of capsular contracture after prosthetic breast reconstruction. Plast Reconstr Surg. 1995 Oct;96(5):1119–23. doi: https://doi.org/10.1097/00006534-199510000-00018
  30. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Mahwah (New Jersey): Lawrence Erlbaum Associates; 1988.
  31. Bayramiçli M, Sirinoglu H, Yalçin D. Outcome After Breast Reduction Considering Body Mass Index and Resection Amount. Aesthet Surg J. 2017 Oct;37(10):1103–10. doi: https://doi.org/10.1093/asj/sjx110
  32. Cabral IV, da Silva Garcia E, Sobrinho RN, Pinto NL, Juliano Y, Veiga-Filho J, et al. Use of the BREAST-Q™ Survey in the Prospective Evaluation of Reduction Mammaplasty Outcomes. Aesthetic Plast Surg. 2018 Apr;42(2):388–95. doi: https://doi.org/10.1007/s00266-017-1009-6
  33. Cabral IV, Garcia ED, Sobrinho RN, Pinto NL, Juliano Y, Veiga-Filho J, et al. Increased Capacity for Work and Productivity After Breast Reduction. Aesthet Surg J. 2017 Jan;37(1):57–62. doi: https://doi.org/10.1093/asj/sjw175
  34. Freire M, Neto MS, Garcia EB, Quaresma MR, Ferreira LM. Functional capacity and postural pain outcomes after reduction mammaplasty. Plast Reconstr Surg. 2007 Apr;119(4):1149–56. doi: https://doi.org/10.1097/01.prs.0000254358.55104.9f
  35. Greco R, Noone B. Evidence-Based Medicine: reduction Mammaplasty. Plast Reconstr Surg. 2017 Jan;139(1):230e–9e. doi: https://doi.org/10.1097/PRS.0000000000002856
  36. Hernanz F, Fidalgo M, Muñoz P, Noriega MG, Gómez-Fleitas M. Impact of reduction mammoplasty on the quality of life of obese patients suffering from symptomatic macromastia: A descriptive cohort study. J Plast Reconstr Aesthet Surg. 2016 Aug;69(8):e168–73. doi: https://doi.org/10.1016/j.bjps.2016.05.012
  37. Knox JA, Nelson DA, Latham KP, Kurina LM. Objective Effects of Breast Reduction Surgery on Physical Fitness. Ann Plast Surg. 2018 Jan;80(1):14–7. doi: https://doi.org/10.1097/SAP.0000000000001167
  38. Mundy LR, Homa K, Klassen AF, Pusic AL, Kerrigan CL. Understanding the Health Burden of Macromastia: Normative Data for the BREAST-Q Reduction Module. Plast Reconstr Surg. 2017 Apr;139(4):846e–53e. doi: https://doi.org/10.1097/PRS.0000000000003171
  39. Schnur PL, Schnur DP, Petty PM, Hanson TJ, Weaver AL. Reduction mammaplasty: an outcome study. Plast Reconstr Surg. 1997 Sep;100(4 Supplement 1):875–83. doi: https://doi.org/10.1097/00006534-199709001-00008
  40. Spector JA, Singh SP, Karp NS. Outcomes after breast reduction: does size really matter? Ann Plast Surg. 2008 May;60(5):505–9. doi: https://doi.org/10.1097/SAP.0b013e31816f76b5
  41. Strong B, Hall-Findlay EJ. How Does Volume of Resection Relate to Symptom Relief for Reduction Mammaplasty Patients? Ann Plast Surg. 2015 Oct;75(4):376–82. doi: https://doi.org/10.1097/SAP.0000000000000190
  42. Boyd CJ, Hemal K, Cohen JM, Daar DA, Gwin J, Zupko K, et al. Preauthorization Inconsistencies Prevail in Reduction Mammaplasty. Plast Reconstr Surg Glob Open. 2023 Oct;11(10):e5361. doi: https://doi.org/10.1097/GOX.0000000000005361
  43. Crittenden T, Watson DI, Ratcliffe J, Griffin PA, Dean NR; AFESA Research Group. Does breast reduction surgery improve health-related quality of life? A prospective cohort study in Australian women. BMJ Open. 2020 Feb;10(2):e031804. doi: https://doi.org/10.1136/bmjopen-2019-031804
  44. Palve J, Kuuskeri M, Luukkaala T, Suorsa E. Predictive risk factors of complications in reduction mammoplasty-analysis of three different pedicles. Gland Surg. 2022 Aug;11(8):1309–22. doi: https://doi.org/10.21037/gs-22-116
  45. Shermak MA, Chang D, Buretta K, Mithani S, Mallalieu J, Manahan M. Increasing age impairs outcomes in breast reduction surgery. Plast Reconstr Surg. 2011 Dec;128(6):1182–7. doi: https://doi.org/10.1097/PRS.0b013e318230c467
  46. Simpson AM, Donato DP, Kwok AC, Agarwal JP. Predictors of complications following breast reduction surgery: A National Surgical Quality Improvement Program study of 16,812 cases. J Plast Reconstr Aesthet Surg. 2019 Jan;72(1):43–51. doi: https://doi.org/10.1016/j.bjps.2018.09.002
  47. Young, ZT, Close M, Herrera FA. National Surgical Quality Improvement Program Analysis of 9110 Reduction Mammaplasty Patients: Identifying Risk Factors Associated With Complications in Patients Older Than 60 Years. Ann Plast Surg. 2019 Jun;82(6S Suppl 5):S446–49. doi: https://doi.org/10.1097/SAP.0000000000001804